Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05750901 · ClinicalTrials.gov registry record · NA
Evaluation of Fractional Ablative Laser Treatment for Skin Conditions
A NA study of Skin Laxity, sponsored by Sciton.
- Recruiting
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 1
- Study location
NCT05750901 is a NA study of Skin Laxity that is actively recruiting participants, run by Sciton. The registered enrollment target is 1,000 participants, above the 91-participant average among 10 other Skin Laxity trials with a reported enrollment target (999% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05750901, a NA study of Skin Laxity, is actively recruiting participants, sponsored by Sciton.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluate the safety and efficacy of the fractional ablative laser for treatment of skin laxity and tightening
Conditions Studied
Interventions
- DEVICE Fractional ablative laser
Study Locations (1)
Florida
- Sanctuary Plastic Surgery - Boca Raton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2026-06-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05750901
The ClinicalTrials.gov registry entry for NCT05750901 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 91-participant average among 10 other Skin Laxity trials with a reported enrollment target (999% higher). The listed sponsor is Sciton, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Skin Laxity appearing as the primary indexed condition, and to 1 intervention - of which Fractional ablative laser is the first listed.
NCT05750901 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05750901 about?
NCT05750901 is a clinical study titled "Evaluation of Fractional Ablative Laser Treatment for Skin Conditions". Evaluate the safety and efficacy of the fractional ablative laser for treatment of skin laxity and tightening
What is the current status of trial NCT05750901?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2022-11-01. Estimated completion is 2026-06-20.
What conditions does trial NCT05750901 study?
This clinical trial studies the following conditions: Skin Laxity.
What interventions are being tested in trial NCT05750901?
The interventions under investigation include: Fractional ablative laser (DEVICE).
Who is sponsoring clinical trial NCT05750901?
This trial is sponsored by Sciton, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05750901 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Laxity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging
RECRUITING · NA
-
An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity
RECRUITING · NA
-
AV-23-001 AVAVA MIRIA Pilot Study
ACTIVE NOT RECRUITING · NA
-
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
ACTIVE NOT RECRUITING · NA
-
Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies
ACTIVE NOT RECRUITING · NA
-
Feasibility Study: Heavy Water Tissue Labeling Protocol
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.